Nutrition in cachexia: from bench to bedside
- PMID: 27030816
- PMCID: PMC4788973
- DOI: 10.1002/jcsm.12111
Nutrition in cachexia: from bench to bedside
Abstract
As malnutrition is often present in cachexia, nutritional intervention has been one of the widely accepted strategies. A literature review of cachexia models with dietary interventions in the present issue of this journal pointed out that the majority of nutrient intervention studies were of n-3 fatty acid, mainly eicosapentaenoic acid and docosahexaenoic acid. Effect on protein catabolism and anti-inflammation are most pronounced benefits of n-3 fatty acid. The effectiveness of n-3 fatty acid may depend on control diet or even be attributed to the polyunsaturated fatty acid deficiency inadvertently produced in control group. However, there is not enough clinical evidence to support a benefit of n-3 fatty acid substitution in patients with cachexia. The second important result from this review is that the majority of studies did not provide information about dietary design or did not standardize design, content, source, and overall composition. To guide dietary design for researchers in preclinical studies, a model has been proposed in this review, which may be useful to predict the efficacy of new dietary intervention in cachexia science. From a clinical point of view, the limited effectiveness of nutritional support in cachexia may partly be explained by the multifactorial nature of this condition. Cachexia differs from malnutrition inasmuch as malnutrition can be reversed by adequate nutrition and/or by overcoming problems of absorption or utilization of nutrients, but cachexia cannot be successfully treated by nutrition alone. Multidisciplinary approach including the assessment and intervention in feeding, appetite, swallowing, exercise, psychosocial, and psychological issue may be needed to improve nutrition in patients with cachexia.
Keywords: Cachexia; Cancer; Diet; Models; Nutrition.
Similar articles
-
Diet composition as a source of variation in experimental animal models of cancer cachexia.J Cachexia Sarcopenia Muscle. 2016 May;7(2):110-25. doi: 10.1002/jcsm.12058. Epub 2015 Oct 15. J Cachexia Sarcopenia Muscle. 2016. PMID: 27493865 Free PMC article. Review.
-
Nutritional counseling and nutritional supplements: a cornerstone of multidisciplinary cancer care for cachectic patients.Curr Opin Support Palliat Care. 2013 Dec;7(4):390-5. doi: 10.1097/SPC.0000000000000016. Curr Opin Support Palliat Care. 2013. PMID: 24189894 Review.
-
New insights on the regulation of cancer cachexia by N-3 polyunsaturated fatty acids.Pharmacol Ther. 2019 Apr;196:117-134. doi: 10.1016/j.pharmthera.2018.12.001. Epub 2018 Dec 4. Pharmacol Ther. 2019. PMID: 30521881 Review.
-
Eicosapentaenoic acid in cancer improves body composition and modulates metabolism.Nutrition. 2015 Apr;31(4):549-55. doi: 10.1016/j.nut.2014.12.002. Epub 2014 Dec 12. Nutrition. 2015. PMID: 25770317 Review.
-
Nutritional management in head and neck cancer: United Kingdom National Multidisciplinary Guidelines.J Laryngol Otol. 2016 May;130(S2):S32-S40. doi: 10.1017/S0022215116000402. J Laryngol Otol. 2016. PMID: 27841109 Free PMC article.
Cited by
-
Body Composition in Patients with Radioactive Iodine-Refractory, Advanced Differentiated Thyroid Cancer Treated with Sorafenib or Placebo: A Retrospective Analysis of the Phase III DECISION Trial.Thyroid. 2019 Dec;29(12):1820-1827. doi: 10.1089/thy.2018.0784. Thyroid. 2019. PMID: 31860408 Free PMC article. Clinical Trial.
-
Targeting the Gut Microbiota to Treat Cachexia.Front Cell Infect Microbiol. 2019 Sep 12;9:305. doi: 10.3389/fcimb.2019.00305. eCollection 2019. Front Cell Infect Microbiol. 2019. PMID: 31572686 Free PMC article. Review.
-
Pathogenesis, Intervention, and Current Status of Drug Development for Sarcopenia: A Review.Biomedicines. 2023 Jun 4;11(6):1635. doi: 10.3390/biomedicines11061635. Biomedicines. 2023. PMID: 37371730 Free PMC article. Review.
-
Pathogenesis and Management of Sarcopenia.Clin Geriatr Med. 2017 Feb;33(1):17-26. doi: 10.1016/j.cger.2016.08.002. Clin Geriatr Med. 2017. PMID: 27886695 Free PMC article. Review.
-
Effect of beta-adrenergic blockade with carvedilol on cachexia in severe chronic heart failure: results from the COPERNICUS trial.J Cachexia Sarcopenia Muscle. 2017 Aug;8(4):549-556. doi: 10.1002/jcsm.12191. Epub 2017 Feb 27. J Cachexia Sarcopenia Muscle. 2017. PMID: 28244261 Free PMC article. Clinical Trial.
References
-
- Evans WJ, Morley JE, Argiles J, Bales C, Baracos V, Guttridge D, et al. Cachexia: a new definition. Clin Nutr 2008;27:793–9. - PubMed
-
- Bauer JD, Ash S, Davidson WL, Hill JM, Brown T, Isenring EA, et al. Evidence based practice guidelines for the nutritional management of cancer cachexia. Nutrition & Dietetics 2006;63:S3–S32.
-
- Baldwin C, Spiro A, Ahern R, Emery PW. Oral nutritional interventions in malnourished patients with cancer: a systematic review and meta‐analysis. J Natl Cancer Inst 2012 Mar 7;104:371–85. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials